Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003539789 | SCV000825947 | uncertain significance | not provided | 2024-10-16 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1929 of the SCN5A protein (p.Arg1929Cys). This variant is present in population databases (rs267599786, gnomAD 0.003%). This missense change has been observed in individual(s) with Brugada syndrome (PMID: 30193851). ClinVar contains an entry for this variant (Variation ID: 75052). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Color Diagnostics, |
RCV001842422 | SCV001734093 | uncertain significance | Cardiac arrhythmia | 2023-10-17 | criteria provided, single submitter | clinical testing | This missense variant replaces arginine with cysteine at codon 1929 of the SCN5A protein. This variant is found within the highly conserved C-terminal region (a.a. 1773-2016). Rare non-truncating variants in this region have been shown to be significantly overrepresented in individuals with Brugada syndrome and long QT syndrome (PMID: 32893267). Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individual(s) affected with Brugada syndrome (PMID: 16643399, 30193851, 32893267). This variant has been identified in 5/280546 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV001842422 | SCV004833803 | uncertain significance | Cardiac arrhythmia | 2024-07-29 | criteria provided, single submitter | clinical testing | This missense variant replaces arginine with cysteine at codon 1929 of the SCN5A protein. This variant is found within the highly conserved C-terminal region (a.a. 1773-2016). Rare non-truncating variants in this region have been shown to be significantly overrepresented in individuals with Brugada syndrome and long QT syndrome (PMID: 32893267). Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individual(s) affected with Brugada syndrome (PMID: 16643399, 30193851, 32893267). This variant has been identified in 5/280546 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Clinical Genetics Laboratory, |
RCV003539789 | SCV005198156 | uncertain significance | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing |